Proto Labs, Inc. (NYSE:PRLB) Shares Acquired by Disciplined Growth Investors Inc. MN

Disciplined Growth Investors Inc. MN lifted its stake in Proto Labs, Inc. (NYSE:PRLB - Free Report) by 5.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,056,593 shares of the industrial products company's stock after purchasing an additional 110,244 shares during the period. Proto Labs makes up 1.1% of Disciplined Growth Investors Inc. MN's investment portfolio, making the stock its 29th largest holding. Disciplined Growth Investors Inc. MN owned 8.39% of Proto Labs worth $60,402,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Canada Pension Plan Investment Board acquired a new position in Proto Labs during the second quarter worth about $37,000. Innealta Capital LLC purchased a new stake in Proto Labs in the 2nd quarter valued at approximately $40,000. KBC Group NV grew its holdings in Proto Labs by 69.3% during the 3rd quarter. KBC Group NV now owns 1,541 shares of the industrial products company's stock valued at $45,000 after buying an additional 631 shares during the last quarter. Meeder Asset Management Inc. purchased a new position in Proto Labs during the second quarter worth $80,000. Finally, Point72 Asia Singapore Pte. Ltd. raised its holdings in shares of Proto Labs by 40.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,108 shares of the industrial products company's stock worth $121,000 after acquiring an additional 1,186 shares during the last quarter. Hedge funds and other institutional investors own 84.54% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on PRLB shares. Needham & Company LLC reiterated a "hold" rating on shares of Proto Labs in a report on Friday, November 1st. Cantor Fitzgerald reissued an "overweight" rating and issued a $40.00 price objective on shares of Proto Labs in a research report on Monday, November 4th. Finally, Craig Hallum lifted their target price on shares of Proto Labs from $30.00 to $36.00 and gave the company a "hold" rating in a report on Monday, November 4th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $40.33.

Proto Labs Trading Up 3.3 %

NYSE:PRLB traded up $1.45 during trading hours on Tuesday, hitting $44.94. The stock had a trading volume of 127,202 shares, compared to its average volume of 201,740. The business has a 50 day simple moving average of $34.30 and a two-hundred day simple moving average of $31.91. Proto Labs, Inc. has a 1-year low of $25.75 and a 1-year high of $45.06. The company has a market cap of $1.10 billion, a PE ratio of 46.27 and a beta of 1.45.

Proto Labs (NYSE:PRLB - Get Free Report) last released its quarterly earnings results on Friday, November 1st. The industrial products company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.15. The firm had revenue of $125.60 million for the quarter, compared to the consensus estimate of $121.38 million. Proto Labs had a net margin of 4.76% and a return on equity of 3.49%. The firm's quarterly revenue was down 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.31 EPS. Research analysts expect that Proto Labs, Inc. will post 0.84 EPS for the current fiscal year.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.